Healthcare Stocks
Johnson & Johnson Forges Ahead with Robust Q2 2025 Performance Amidst Strategic Growth Initiatives
NEW BRUNSWICK, NJ – July 16, 2025 – In a testament to its enduring strength and adaptive strategy, Johnson & Johnson (NYSE: JNJ) today...